StonvexLoading…
StonvexStonvexStonvexCore line items from BTCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.49M | $4.07M | $1.34M | $1.69M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-33.35M | $-1.27M | $7.82M | $-15.89M |
EPS (Diluted) | $-1.00 | $-0.08 | $0.45 | $-1.25 |
Total Assets | $214.63M | $38.25M | $27.15M | $9.92M |
Total Liabilities | $75.22M | $4.25M | Not available | Not available |
Cash & Equivalents | $1.53M | $1.98M | $1.46M | $2.15M |
Free Cash Flow OCF − CapEx | $-9.80M | $-3.53M | $-3.57M | $-782.18K |
Shares Outstanding | 46.85M | 18.72M | 15.32M | 13.11M |